Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Author Archives: NellieGay
Cancer Genetics IPO Faces Facebook
Cancer Genetics is pursuing a strategy that differs from Facebook’s IPO plan, expert says. A Rutherford, N.J.-based start-up developing tools to diagnose cancer is planning to launch an initial public offering this week under the long shadow of Facebook’s long-awaited blockbuster IPO. Cancer Genetics Inc Continue reading
Posted in Genetics
Tagged a-quick-profit, below-the-peak, chairman, chairman-raju, chance, chief-executive, florida, long, nasdaq, nasdaq-stock, north-jersey, officer-panna, period-it-takes
Comments Off
Fibrocell Science Technology Leads to Discovery of Two Rare Adult Stem Cell-Like Subpopulations in Human Skin
EXTON, Pa.–(BUSINESS WIRE)– In collaboration with Fibrocell Science, Inc., (OTCBB:FCSC.OB), researchers at the University of California, Los Angeles (UCLA) have identified two rare adult stem cell-like subpopulations in adult human skin, a discovery that may yield further ground-breaking research in the field of personalized medicine for a broad range of diseases. Using technology developed by Fibrocell Science, Inc. the researchers were able to confirm the existence of these two types of cells in human skin cell cultures, potentially providing a source of stem cell-like subpopulations from skin biopsies, which are quicker to perform, relatively painless and less invasive than bone marrow and adipose tissue extractions, which are the current methods for deriving adult stem cells for patient-specific cellular therapies. Continue reading
Posted in Cell Medicine
Tagged california-, fibrocell, identification, method, regenerative, research, skin, the-researchers, ucla, university, within-the-skin
Comments Off
SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC
SACRAMENTO, Calif., April 19, 2012 /PRNewswire/ — SynGen Inc. (“SynGen” or the “Company”), a Regenerative Medicine device company focused on the development of next generation stem cell harvesting systems, announced today that it has completed a $5 million Series A preferred stock financing with Bay City Capital, LLC (BCC) Continue reading
Posted in Regenerative Medicine
Tagged a-life-sciences, a-top-tier, capital, development, during-the-due, focused-on-the, make-the-syngen, opportunity, partner-at-bay, substantially, syngen, under-the-terms, william-gerber
Comments Off
Veterinarians stress the need for heartworm preventatives
With the population of mosquitos thriving, thanks to the warm winter and heavy rains, your dog could be at greater risk for heartworm disease. Preventative medications are still your best bet to protect your pet. Veterinarian Dr Continue reading
Posted in Preventative Medicine
Tagged a-yellow-lab, death-sentence, disease-mimics, going-on-right, had-heartworms, heart-failure, like-coughing, look-at-the, mosquito-bites, population, preventative, protecting-now-, the-population
Comments Off
Stem cell therapy possibly helpful in heart failure patients
Public release date: 24-Mar-2012 [ | E-mail | Share ] Contact: Beth Casteel bcasteel@acc.org 240-328-4549 American College of Cardiology CHICAGO — A new study found that using a patient’s own bone marrow cells may help repair damaged areas of the heart caused by heart failure, according to research presented today at the American College of Cardiology’s 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field. Continue reading
Posted in Stem Cell Therapy
Tagged a-catheter-into, a-small-but, cardiology-, heart, improvement, national, network, sciences-at-the, sonia-skarlatos, study, the-heart-, with-the-number
Comments Off
BioTime CEO Michael D. West to Present at 2012 Maxim Group Growth Conference
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer, Michael D. Continue reading
Posted in Regenerative Medicine
Tagged a-high-unmet, a-wide-array, business, california-, healthcare, investors, maxim-group, results, south-korea, statements, treatment
Comments Off
9/11 Search And Rescue Dog Gets Stem Cell Treatment
BURKE, Va. Continue reading
Posted in Stem Cell Therapy
Tagged a-black-lab, a-few-hours, a-search-and, america, burke, extracted, first-injection, heather-roche, pentagon, same, search-and, small-something, spent-the-last, treatment
Comments Off
California's stem cell agency ponders its future
LOS ANGELES (AP) The creation of California’s stem cell agency in 2004 was greeted by scientists and patients as a turning point in a field mired in debates about the destruction of embryos and hampered by federal research restrictions. The taxpayer-funded institute wielded the extraordinary power to dole out $3 billion in bond proceeds to fund embryonic stem cell work with an eye toward treatments for a host of crippling diseases Continue reading
Posted in Cell Medicine
Tagged a-field-mired, a-pro-stem-cell, again-on-voters, assumes-it-will, chairman, Genetics, given-the-state, marcy-darnovsky, money, possibility, society, state
Comments Off
Top Scientists from US, Canada, and Australia, Member of the Canadian Parliament and Stryker Executive to be Honored …
WEST HOLLYWWOOD, Calif., March16, 2012 /PRNewswire/ –Today, the Society for Brain Mapping & Therapeutics announced the 2012 recipients of the organization’s prestigious Pioneers in Medicine, Technology, and Healthcare Policy Awards. The Society will honor each recipient at the Brain Mapping Foundation’s Gala on June 1, 2012 as part of their 9th Annual World Congress in Toronto, Canada. Continue reading
Posted in Nano medicine
Tagged california-, development, governor, medicine, president, senator, technology, toronto
Comments Off
StemCells, Inc. Reports Fourth Quarter and Year End 2011 Financial Results and Provides Business Update
NEWARK, Calif., March 13, 2012 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM – News), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today reported financial results for the fourth quarter and year ended December 31, 2011 and provided a business update. “The StemCells team made significant progress in 2011 with regard to two critical goals for the Company, namely accelerating and broadening our HuCNS-SC neural stem cell clinical trial agenda for diseases of, and injuries to, the central nervous system, while at the same time reducing our operating cash burn. Continue reading
Posted in Stem Cell Therapy
Tagged business, european, impairment, paris, proprietary, recent-business, the-fourth, tools
Comments Off
3D-printer with nano-precision
The 3D printer uses a liquid resin, which is hardened at precisely the correct spots by a focused laser beam. Continue reading
Posted in Nano medicine
Tagged a-few-hundred, a-focused-laser, a-world-record-, bridge-credit, browser, london-tower, professor, professor-jrgen, time
Comments Off
Correcting human mitochondrial mutations
Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California – Los Angeles Health Sciences Researchers at the UCLA stem cell center and the departments of chemistry and biochemistry and pathology and laboratory medicine have identified, for the first time, a generic way to correct mutations in human mitochondrial DNA by targeting corrective RNAs, a finding with implications for treating a host of mitochondrial diseases. Continue reading
Posted in Stem Cell Therapy
Tagged a-broad-range, a-generic-way, a-have-remained, a-very-reasoned, angeles-health, california-, dna, energy, mitochondria, mitochondrial, peer, research-center
Comments Off
Stem Cell-Seeded Cardiopatch Could Deliver Results for Damaged Hearts
A new type of stem cell-seeded patch has shown promising results in promoting healing after a heart attack, according to a study released today in the journal STEM CELLS Translational Medicine. Durham, NC (PRWEB) March 07, 2012 Ischemic heart disease, caused by vessel blockage, is a leading cause of death in many western countries. Studies have shown the potential of stem cells in regenerating heart tissue damaged during an attack Continue reading
Posted in Cell Medicine
Tagged animals, engraftment, heart, hearts, journal, marisa-jaconi, medicine, researchers
Comments Off
It's not pulp fiction
Stem cell therapy is poised to become the next big thing in the treatment of major diseases. Even those extracted from dental pulp can be preserved for future use Watching his five-year-old pull at his loose tooth, dad Shekar remembered something he had read in a dental clinic. Continue reading
Posted in Stem Cell Therapy
Tagged a-better-option, a-house-lizard, a-major-ailment, country, effectiveness, management, medical-, shailesh-gadre
Comments Off
Pat was Diagnosed with “CMT” Disease and was Given a Second Chance with a Stem Cell Treatment
Pat receive a life altering Stem Cell Treatment with the help of World Stem Cells, LLC. Pat went from couch bound to walking 1.5 miles on country dirt road, climbing stairs, gardening and playing piano all thanks to a stem cell treatment. (PRWEB) March 03, 2012 Pats neurological disorder is hereditary, and the official position of the National Institute of Neurological Disorders and Stroke is that CMT has no cure. Continue reading
Posted in Stem Cell Therapy
Tagged a-bright-future, a-four-leg-quad, a-life-altering, cells, health, hematology, international, life, management, medicine, president, surgeries, world, world-stem
Comments Off
Advanced Cell Technology To Announce 2011 Fourth Quarter and Year-End Results on March 1st
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will release 2011 fourth quarter and year-end results on Thursday, March 1st after the market closes. The Company will hold a conference call on Friday, March 2nd at 9:00 am eastern time to discuss the results and provide an update on clinical activities Continue reading
Posted in Regenerative Medicine
Tagged advanced-cell, based-on-the, call-on-friday, circumstances, development, field, news, private, reference-, results, statements, technology, time, words
Comments Off
The Genetics of Luck
At the 2010 Comic-Con in San Diego, a number of people were asked what they thought to be the greatest superpower. Stan Lee, the creator of Spider-Man and The Fantastic Four (among many others), said it was “good luck,” because nothing can go wrong if you have good luck Continue reading
Posted in Genetics
Tagged a-more-rigorous, fantastic-four, image, larry-niven, manufacturer, numbers, ramifications, reading
Comments Off
Massachusetts General researchers discover stem cell that makes eggs
By Carolyn Y. Johnson, Globe Staff Massachusetts General Hospital researchers reported today they have discovered a rare stem cell in women’s ovaries that they hope one day might be used to make eggs, a claim already generating vigorous debate among scientists familiar with the research. Continue reading
Posted in Cell Medicine
Tagged fertility, findings, japan, journal, massachusetts, medical-, medicine, ovaries, research, scotland-, startup, stem, technology
Comments Off
Ogden family at center of ethics debate in genetics research
Ogden • By the time Camilla Black Grondahl became pregnant with her second child in 2010, she had already watched two older sisters bury sons who were born with a congenital affliction that gave them the appearance of “little old men.” Various health problems made their survival impossible. The young mother did not know whether she, too, could pass the condition to her unborn son. But a Utah researcher, who had been sequencing her family’s genes, did know. Continue reading
Posted in Genetics
Tagged a-50-50-chance, chairman, data-, dna, grondahl, grondahls, human-genetics, nature, pregnancy-, research, spring, time, university
Comments Off